쇼트코스

Sunday, April 7

Morning, 10:00 am - 1:00 pm

쇼트코스1: 면역원성의 전임상 평가와 임상 평가:유전자 치료 및 CAR-T세포치료를 포함한 멀티도메인의 치료법과 새로운 모달리티

Darshana Jani, MSc, Associate Director, Global Lead Biologics, Clinical Assay Group, Global Product Development, Pfizer, Inc.

Magdalena Tary-Lehmann, MD, PhD, CSO, Cellular Technology Limited (CTL); Adjunct Associate Professor of Pathology, Case Western Reserve University (CWRU) 

Rama Boyanapalli, PhD, Associate Director, Bioanalytical and Biomarker Development, Wave Life Sciences 

Linzhi Chen, PhD, Senior Research Fellow & Bioanalytical Group Leader, Boehringer Ingelheim Pharmaceuticals

쇼트코스2: 중개연구에 의한 생물학적 제제 개발 전략 파트 1:발견, 분자적 평가, 조기 단계의 개발 - 상세 아젠다

Juan Carlos Almagro, PhD, Founder and Director, GlobalBio, Inc.

Zhiqiang An, PhD, Professor, Chemistry; Director, Texas Therapeutics Institute, University of Texas Health Science Center at Houston

Gadi Bornstein, PhD, Senior Director, Biologics Discovery, TESARO, Inc.

쇼트코스3: 친화성 시약의 선택, 스크리닝, 엔지니어링

Jonas V. Schaefer, PhD, Lab Head/Investigator II, Novartis Institutes for BioMedical Research (NIBR)

Christian Kunz, PhD, Director, MorphoSys AG

쇼트코스4: 면역치료용 종양 미세환경의 연구와 조절

David A. Eavarone, PhD, Associate Principal Scientist, Harbour Biomed

Afternoon, 2:30 - 5:30 pm

쇼트코스5: 인실리코 면역원성 예측에 관한 (실기) 워크샵

Vinodh B. Kurella, PhD, Principal Scientist, Protein Engineering, Merrimack Pharmaceuticals

Daron Forman, PhD, Principal Scientist, Molecular Discovery Technologies, Bristol-Myers Squibb

쇼트코스6: 숙주세포 단백질 입문:분석법, 특성 평가, 리스크, 요건

Denise Krawitz, PhD, Principal Consultant, CMC Paradigms LLC

쇼트코스7: 중개연구에 의한 생물학적 제제 개발 전략 파트 2:분석과 임상 연구의 문제 - 상세 아젠다

Zhiqiang An, PhD, Professor, Chemistry; Director, Texas Therapeutics Institute, University of Texas Health Science Center at Houston

Scott L. Klakamp, PhD, Senior Director & Head, Biophysics, Biologics Development Sciences, Janssen BioTherapeutics

Liming Liu, PhD, Senior Principal Scientist, Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM), Merck Research Laboratories

An Song, PhD, Senior Vice President, Development Sciences, Immune-Onc Therapeutics, Inc.

쇼트코스8: 유전자 치료용 제품:개발 단계에 적합한 분석법의 개발 전략 - 상세 아젠다

Francis Poulin, PhD, Director, Analytical Development, Sanofi

Claire Davies, PhD, Associate Vice President, Bioanalytics, Sanofi

Tuesday, April 9

DINNER, 6:00 - 8:30 pm

쇼트코스9: 생물학적 제제용 생물물리학적 분석법 입문:개발에 대한 응용 - 상세 아젠다

Christine P. Chan, PhD, Principal Scientist, Global Manufacturing Science & Technology, Sanofi

쇼트코스10: 고형암용 CAR-T세포치료

Soldano Ferrone, MD, PhD, Division of Surgical Oncology, Surgery, Massachusetts General Hospital, Harvard Medical School

Moonsoo M. Jin, PhD, Associate Professor, Molecular Imaging Innovations Institute, Radiology, Weill Cornell Medical College

Tara Arvedson, PhD, Director, Oncology Research, Amgen

쇼트코스11: 이중특이성항체의 발전성:포맷과 응용 분야

Nimish Gera, PhD, Director, Research and Development, Mythic Therapeutics

Thursday, April 11

dinner, 5:45 - 8:15 pm

쇼트코스12: 항체약물결합체의 설계 전략과 개발 - 상세 아젠다

Robert Lutz, PhD, Principal Consultant, Crescendo Biopharma Consulting

쇼트코스13: 바이오어세이의 QbD(Quality by Design)

Thomas Little, PhD, President and CEO, Bioassay Sciences, Thomas A. Little Consulting

쇼트코스14: 면역원성 연구 분야의 Subvisible 단백질 입자:측정, 특성 평가, 영향

Björn Boll, PhD, Head, Particle Lab and Higher Order Structure Protein Analytics, Physical Chemical Analytics, Novartis Pharma AG

Antonio Iglesias, PhD, Expert Scientist, Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, Ltd. Basel

dINNER, 5:45 - 8:45 pm

쇼트코스15: 포유류 세포에서의 일과성 단백질 발현

Richard Altman, MS, Scientist, Protein Technologies, Amgen

Henry C. Chiou, PhD, Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific

Dominic Esposito, PhD, Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research


* Separate Registration Required.

* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English



Catalog Download
Catalog

Premier Sponsors


표시 유형:



메일링 서비스
메일링 서비스